Product Information

FEBUXOSTAT 40 MG TABLET is a generic product labeled by Novadoz Pharmaceuticals LLC, priced at $0.2114 per EA under NDC 72205002830. Its NADAC has been published 328 times since May 13, 2020.

FDA first approved this application on Dec 30, 2019. Its Orange Book therapeutic-equivalence code is AB — FDA rates it therapeutically equivalent to (substitutable for) its reference product.

FEBUXOSTAT 40 MG TABLET

Febuxostat
$0.2114per EA

Strength

40 mg/1

NDC

72205002830

Classification

Generic

Dosage Form

TABLET, FILM COATED

Route

ORAL

Effective Date

8/19/2026

Active Ingredients

FEBUXOSTAT

Approval Type

Generic (ANDA)

FDA Application

ANDA210461

FDA Approved

12/30/2019

TE Code

AB

On Market Since

12/30/2019

Pharmacological Classes

Xanthine Oxidase Inhibitor
Xanthine Oxidase Inhibitors

Price Statistics

The NADAC for FEBUXOSTAT 40 MG TABLET has been published 328 times since May 13, 2020, and over the history we have for it it has declined 90.9%. The table below summarizes its recorded NADAC range and movement.

Current price$0.2114 per EA
All-time high$2.4948 (Jun 10, 2020)
All-time low$0.2016 (Jan 21, 2026)
52-week high$0.2818
52-week low$0.2016
Median price$0.5949
Average price$0.7544
Largest weekly change-29.6% (Apr 17, 2024)
Weeks tracked328
Tracking sinceMay 13, 2020

Price History

1W

-0.1%

1M

-0.1%

3M

-0.1%

6M

+4.3%

1Y

-25.0%

3Y

-69.4%

5Y

-80.3%

All

-90.9%

Generic Alternatives

The matcher finds 7 manufacturers offering a NADAC-published product with this drug's active ingredient and strength in a comparable dosage form (cheapest from each manufacturer, up to 10 shown below). None of the shown alternatives sit below the current price. These are candidates to verify clinically, not guaranteed substitutes — see our generic drug prices guide.

Frequently asked questions

What is the NADAC price of FEBUXOSTAT 40 MG TABLET?

The current National Average Drug Acquisition Cost (NADAC) for FEBUXOSTAT 40 MG TABLET, manufactured by Novadoz Pharmaceuticals LLC, is $0.2114 per EA (NDC 72205002830), effective Aug 19, 2026.

How has the price of FEBUXOSTAT 40 MG TABLET changed over time?

Over the history we have for it, the NADAC for FEBUXOSTAT 40 MG TABLET has declined 90.9%. It has been tracked across 328 weekly CMS publications since May 13, 2020.

What are the highest and lowest recorded NADAC prices for FEBUXOSTAT 40 MG TABLET?

Since May 13, 2020, the NADAC for FEBUXOSTAT 40 MG TABLET has ranged from a low of $0.2016 (Jan 21, 2026) to a high of $2.4948 (Jun 10, 2020), with a median of $0.5949 per EA.

Are there cheaper alternatives to FEBUXOSTAT 40 MG TABLET?

7 manufacturers publish a NADAC-priced product with the same active ingredient and strength as FEBUXOSTAT 40 MG TABLET in a comparable dosage form, but none are currently priced below it.

Who manufactures FEBUXOSTAT 40 MG TABLET?

FEBUXOSTAT 40 MG TABLET (NDC 72205002830) is labeled by Novadoz Pharmaceuticals LLC, and CMS classifies it as a generic product.